Literature DB >> 11021767

Prevalence of the sleep apnea syndrome in acromegaly population.

V Weiss1, K Sonka, M Pretl, S Dostálová, J Klozar, P Rambousek, J Marek, T Haas.   

Abstract

The prevalence of sleep apnea syndrome (SAS) in acromegaly is high. Consequences of SAS are serious and are associated with increased morbidity and mortality. The aim of this study was to assess the relative frequency and predictive factors for SAS in a group of patients with acromegaly (n=55). The presence of SAS was evaluated using the Polymesam device. Hormonal and clinical examination consisted of assessment of growth hormone, insulin-like growth factor I plasma levels, body mass index (BMI), neck circumference, age, sex, treatment modes of acromegaly and ear, nose and throat (ENT) examination. The relative frequency of SAS in our group of patients with acromegaly was 75%. Independent predictors of SAS were: increased activity of acromegaly, higher age and neck circumference. No association between SAS and BMI and ENT findings was observed. The role of gender was controversial.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11021767     DOI: 10.1007/BF03343767

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  [Disappearance of the sleep apnea syndrome in a female patient after surgery of a hypophyseal adenoma with acromegaly].

Authors:  V Weiss; M Pretl; K Sonka
Journal:  Vnitr Lek       Date:  1997-06

Review 2.  ABC of sleep disorders. The sleep apnoea/hypopnoea syndrome and snoring.

Authors:  N J Douglas
Journal:  BMJ       Date:  1993-04-17

Review 3.  Sleep apnea syndrome: recent advances.

Authors:  C Guilleminault; J Cummiskey; W C Dement
Journal:  Adv Intern Med       Date:  1980

4.  Sleep apnea in acromegaly.

Authors:  R R Grunstein; K Y Ho; C E Sullivan
Journal:  Ann Intern Med       Date:  1991-10-01       Impact factor: 25.391

Review 5.  Epidemiology of obstructive sleep apnea syndrome.

Authors:  M Partinen; T Telakivi
Journal:  Sleep       Date:  1992-12       Impact factor: 5.849

6.  Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly.

Authors:  R R Grunstein; K Y Ho; M Berthon-Jones; D Stewart; C E Sullivan
Journal:  Am J Respir Crit Care Med       Date:  1994-08       Impact factor: 21.405

7.  Obstructive sleep apnea syndrome and acromegaly.

Authors:  S A Mickelson; L D Rosenthal; J P Rock; B A Senior; M E Friduss
Journal:  Otolaryngol Head Neck Surg       Date:  1994-07       Impact factor: 3.497

8.  Sleep apnea in active acromegaly.

Authors:  T B Hart; S K Radow; W G Blackard; H S Tucker; K R Cooper
Journal:  Arch Intern Med       Date:  1985-05

9.  Sleep apnoea and daytime sleepiness in acromegaly: relationship to endocrinological factors.

Authors:  T Pekkarinen; M Partinen; R Pelkonen; M Iivanainen
Journal:  Clin Endocrinol (Oxf)       Date:  1987-12       Impact factor: 3.478

10.  Respiratory problems and acromegaly. An acromegalic with hypersomnia, acute upper airway obstruction and pulmonary oedema.

Authors:  D R Goldhill; J G Dalgleish; R H Lake
Journal:  Anaesthesia       Date:  1982-12       Impact factor: 6.955

View more
  18 in total

1.  SLEEP DISORDERED BREATHING AND METABOLIC EFFECTS: EVIDENCE FROM ANIMAL MODELS.

Authors:  Jonathan Jun; Vsevolod Y Polotsky
Journal:  Sleep Med Clin       Date:  2007-06

2.  Screening of acromegaly in adults with obstructive sleep apnea: is it worthwhile?

Authors:  Pierre Attal; Philippe Chanson
Journal:  Endocrine       Date:  2018-05-22       Impact factor: 3.633

3.  Elevated incidence of sleep apnoea in acromegaly-correlation to disease activity.

Authors:  J Roemmler; B Gutt; R Fischer; S Vay; A Wiesmeth; M Bidlingmaier; J Schopohl; M Angstwurm
Journal:  Sleep Breath       Date:  2012-01-13       Impact factor: 2.816

Review 4.  Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly.

Authors:  Federico Gatto; Claudia Campana; Francesco Cocchiara; Giuliana Corica; Manuela Albertelli; Mara Boschetti; Gianluigi Zona; Diego Criminelli; Massimo Giusti; Diego Ferone
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

Review 5.  Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.

Authors:  Rosario Pivonello; Renata S Auriemma; Ludovica F S Grasso; Claudia Pivonello; Chiara Simeoli; Roberta Patalano; Mariano Galdiero; Annamaria Colao
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

6.  Morphological study of upper airways and long-term follow-up of obstructive sleep apnea syndrome in acromegalic patients.

Authors:  Cinzia Castellani; Giuseppe Francia; Luca Dalle Carbonare; Marcello Ferrari; Elena Viva; Roberto Cerini; Alessandro Zaccarella; Lorenzo Trevisiol; Maria Vittoria Davi'
Journal:  Endocrine       Date:  2015-06-21       Impact factor: 3.633

7.  Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group.

Authors:  E De Menis; A Giustina; A Colao; E Degli Uberti; E Ghigo; F Minuto; F Bogazzi; R Drigo; A Cattaneo; G Aimaretti
Journal:  J Endocrinol Invest       Date:  2011-01       Impact factor: 4.256

Review 8.  Sleep apnoea in the older adult : pathophysiology, epidemiology, consequences and management.

Authors:  Tamar Shochat; Giora Pillar
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 9.  Acromegaly in the elderly patients.

Authors:  Maria Rosaria Ambrosio; Irene Gagliardi; Sabrina Chiloiro; Ana Gonçalves Ferreira; Marta Bondanelli; Antonella Giampietro; Antonio Bianchi; Laura De Marinis; Maria Fleseriu; Maria Chiara Zatelli
Journal:  Endocrine       Date:  2020-02-14       Impact factor: 3.633

10.  The posterior pharyngeal wall thickness is associated with OSAHS in patients with acromegaly and correlates with IGF-1 levels.

Authors:  Xiaopeng Guo; Yumo Zhao; Man Wang; Lu Gao; Zihao Wang; Zhuhua Zhang; Bing Xing
Journal:  Endocrine       Date:  2018-06-21       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.